Invention Grant
- Patent Title: Fused pyridine derivatives useful as c-Met tyrosine kinase inhibitors
-
Application No.: US14411515Application Date: 2013-07-01
-
Publication No.: US09617257B2Publication Date: 2017-04-11
- Inventor: Shaojing Hu , Fei Wang , Zhiguo Xu , Yanping Wang , Yinxiang Wang
- Applicant: BETA PHARMACEUTICALS CO., LTD.
- Applicant Address: CN Hangzhou
- Assignee: Betta Pharmaceuticals Co., LTD
- Current Assignee: Betta Pharmaceuticals Co., LTD
- Current Assignee Address: CN Hangzhou
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Priority: WOPCT/CN2012/077924 20120629
- International Application: PCT/CN2013/078592 WO 20130701
- International Announcement: WO2014/000713 WO 20140103
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D498/04 ; C07D513/04
Abstract:
This invention relates to novel fused quinazoline derivatives of Formula I as c-Met inhibitors, their synthesis and uses for treating c-Met mediated disorders.
Public/Granted literature
- US20150315210A1 NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS Public/Granted day:2015-11-05
Information query
